Data as of May 21
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for SCOLR Pharma Inc have a median target of 6.96, with a high estimate of 6.96 and a low estimate of 6.96. The median estimate represents a +579,900.00% increase from the last price of 0.00.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.